Fig. 2.
(Top) Locoregional control (LRC) as a function of response to neoadjuvant chemotherapy. (Bottom left) LRC in patients who experienced at least a PR to chemotherapy as a function of radiation dose (n = 94 for dose 66 Gy, n = 59 for 60 Gy). (Bottom right) LRC in patients who experienced less than a PR to chemotherapy as a function of radiation dose (n = 14 for dose 66 Gy, n = 16 for 60 Gy).